ClinicalTrials.Veeva

Menu

Pilot Study for the Validity of a Content-based Information Provision Tool Aimed at Improving the Hospitalization Experience of Liver Transplant Patients

Samsung Medical Center logo

Samsung Medical Center

Status

Not yet enrolling

Conditions

Liver Transplantation
Inpatients

Treatments

Other: Consolidating content on a single website and providing access to it via QR codes in a brochure format

Study type

Interventional

Funder types

Other

Identifiers

NCT06424808
2024-04-078-001

Details and patient eligibility

About

The investigators aim to evaluate the improvement of the inpatient experience and the usability of a content-based tool (a brochure). This involves consolidating video content for inpatients on a single website and providing access to it via QR codes in a brochure format.

[Patients] Considering this as a pilot study, the investigators plan to recruit around 30 participants. Both the experimental and control groups will receive standard care and information, with the experimental group additionally receiving the brochure. Random assignment will be used for the experimental and control groups. Surveys and interviews will be conducted to assess changes in patient experience and usability before and after providing the brochure.

[Medical Staff] Among the medical staff involved in the liver transplant surgical process, researchers will select participants based on their degree of involvement with the intervention subjects. After obtaining their consent, interviews will be conducted concerning patient experiences and the brochure.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

[Patients]

  • Adults aged 18 and over
  • Patients who are scheduled to undergo or have undergone liver transplant surgery
  • Recruited through a call for research participants and have consented to participate in this study

[Medical Staff]

  • Adults aged 18 and over
  • Medical staff at Samsung Medical Center involved in the post-liver transplant treatment process

Exclusion criteria

[Patients]

  • Individuals who have not consented to participate in this study
  • Individuals whose health condition makes it difficult to participate in the intervention
  • During the research period, the researcher will check if the brochure content has been shared during surveys or interviews with the research participants (information dissemination). If information dissemination is confirmed, the participant will be excluded from the study.

[Medical Staff]

  • Individuals who have not consented to participate in this study
  • Medical staff not involved in the liver transplant treatment process

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Control Group
No Intervention group
Description:
1. The group assigned as the control group will receive information in the same manner as it is currently provided to patients. 2. A survey related to patient experience evaluation will be conducted before discharge. The survey will take about 10 minutes. 3. The control group will undergo two interviews, one during hospitalization and one before discharge. Each interview will last approximately 30 minutes. Interviews will be recorded or transcribed, and the recordings will be used until the research objectives are met, after which they will be disposed of.
Experimental Group
Experimental group
Description:
1. The group assigned as the experimental group will receive information in the same manner as it is currently provided to patients, with the addition of a brochure provided once when moving to a general ward after surgery. The brochure can then be used freely. 2. A survey related to patient experience evaluation will be conducted before discharge. For the experimental group, an additional survey regarding the provided brochure will be included. The survey will take about 15 minutes. 3. The experimental group will undergo two interviews, one during hospitalization and one before discharge. Each interview will last approximately 30 minutes. Interviews will be recorded or transcribed, and the recordings will be used until the research objectives are met, after which they will be disposed of.
Treatment:
Other: Consolidating content on a single website and providing access to it via QR codes in a brochure format

Trial contacts and locations

0

Loading...

Central trial contact

Su Min Kim, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems